<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-160018</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Neuroprotective effect of sevoflurane in general anaesthesia</dc:title>
<dc:description xml:lang="en">Introduction and objective: The aim of this study was to evaluate the brain damage caused by inhaled sevoflurane, by determining the concentration of serum S100B protein before and after the exposure to this drug as the only anaesthetic agent. Patients and method: Paediatric patients undergoing general anaesthesia for the conduct of a nuclear magnetic resonance were included in the study. A venous blood sample was taken from each patient before (basal sample) and after (post-exposure sample) administering the general anaesthesia. The concentration of serum S100B protein was determined in the basal (S100Bb) and post-exposure sample (S100Bp). Results: A total of 72 patients were included in the study, with a mean patient age of 2 to 13 years (median = 6), 28 males and 44 females. S100Bp values (median = 66.5 ng/L) were significantly lower (P = .0059) than those of S100Bb (median = 84.0 ng/L). The median of the difference between S100Bp and S100Bb was &amp;#8722;11.0 ng/L. Conclusions: Inhaled sevoflurane at low doses causes a decrease of serum S100B protein levels, hence, this drug could have a neuroprotective effect in the central nervous system (AU)</dc:description>
<dc:creator>Mesa Suárez, Pablo</dc:creator>
<dc:creator>Santotoribio, José Diego</dc:creator>
<dc:creator>Ramos Ramos, Victoria</dc:creator>
<dc:creator>Muñoz Hoyos, Antonio</dc:creator>
<dc:creator>González García, María Ángela</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivo: El objetivo fue evaluar el daño cerebral producido por el sevoflurano inhalado mediante la determinación de la proteína S100B sérica antes y después de una exposición a este fármaco como único agente anestésico. Pacientes y método: Se incluyeron pacientes pediátricos sometidos a resonancia magnética nuclear bajo anestesia general con sevoflurano inhalado a dosis baja. A todos los pacientes se les extrajo una muestra de sangre venosa, antes (muestra basal) y después de la anestesia general (muestra postexposición). Se determinó la concentración de la proteína S100B sérica en la muestra basal (S100Bb) y en la muestra postexposición (S100Bp). Resultados: Se incluyeron 72 pacientes entre 2 y 13 años (mediana = 6), 28 niños y 44 niñas. Los valores de S100Bp (mediana = 66,5 ng/l) fueron significativamente inferiores (p = 0,0059) a los de S100Bb (mediana = 84,0 ng/l). La mediana de las diferencias entre S100Bp y S100Bb resultó &amp;#8722;11,0 ng/l. Conclusiones: El sevoflurano inhalado a dosis bajas produce un descenso de la proteína S100B sérica, por lo que este fármaco podría tener un efecto neuroprotector a nivel del sistema nervioso central (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);148(4): 158-160, feb. 2017. tab</dc:source>
<dc:identifier>ibc-160018</dc:identifier>
<dc:title xml:lang="es">Efecto neuroprotector del sevoflurano en anestesia general</dc:title>
<dc:subject>^d779^s22039</dc:subject>
<dc:subject>^d779^s22045</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d24250^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d22935^s22045</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d32116^s22073</dc:subject>
<dc:subject>^d1953^s22036</dc:subject>
<dc:subject>^d2525^s22021</dc:subject>
<dc:subject>^d1953^s22012</dc:subject>
<dc:subject>^d23405^s22045</dc:subject>
<dc:subject>^d32116^s22044</dc:subject>
<dc:subject>^d788^s22020</dc:subject>
<dc:type>article</dc:type>
<dc:date>201702</dc:date>
</metadata>
</record>
</ibecs-document>
